CytoDyn Requests “Fast Track Approval” for COV
Post# of 148278
(Total Views: 756)
Posted On: 08/19/2020 1:26:22 AM
CytoDyn Requests “Fast Track Approval” for COVID-19 Patients from U.K.’s Regulatory Agency MHRA based on its Top-line Report Showing Statistically Significant Endpoint, NEWS2 (p < 0.023) and Notable Safety Results
https://www.cytodyn.com/newsroom/press-releas...r-covid-19
https://www.cytodyn.com/newsroom/press-releas...r-covid-19
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼